EMD Ann: Ethics approval received for EMD-RX5 Phase 1 Study - 3rd Mar 2022, 1:41pm

annb0t

annb0t

Top 20
EMD Ann: Ethics approval received for EMD-RX5 Phase 1 Study
Price Sensitive: Y
Date: 3rd Mar 2022, 1:41pm

>>> Read announcement: Google: EMD Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
EMD Ann: Emyria Secures Ethics Endorsement for MDMA AP Application - 30th Oct 2023, 9:23am
Replies
0
Views
67
annb0t
annb0t
annb0t
EMD Ann: Emyria Receives Ethics Approval for MDMA-assisted Therapy - 8th Jun 2023, 9:10am
Replies
0
Views
94
annb0t
annb0t
annb0t
EMD Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial - 16th Aug 2022, 9:45am
Replies
0
Views
184
annb0t
annb0t
annb0t
EMD Ann: Results of General Meeting - 31st Oct 2023, 3:43pm
Replies
0
Views
79
annb0t
annb0t
annb0t
EMD Ann: ASA Virtual Investor Summit Presentation October 2023 - 27th Oct 2023, 8:04am
Replies
0
Views
130
annb0t
annb0t
Top Bottom